Compare Heron Therapeutics Inc (HRTX) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs United Parcel Service Inc — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while United Parcel Service Inc trades at $94.37 (market cap $78.52B). The key difference: United Parcel Service Inc is far larger — about 1060.5× Heron Therapeutics Inc's market cap, and United Parcel Service Inc pays a 7.11% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and United Parcel Service Inc for 141 Days on average.
| HRTX | UPS | |
|---|---|---|
Market Cap | $74.04M | $78.52B |
Volume | 3,668,095 | 5,159,366 |
Sector | Health | Industrials |
52-Week High | $1.49 | $120.00 |
52-Week Low | $0.27 | $82.87 |
Typical Hold Time | 35 Days | 141 Days |
Enterprise Value | $180.78M | $102.54B |
Dividend Yield | — | 7.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
UPS trades at $94.11, up 1.07% with bearish technical signals but strong fundamentals including a 17.15 P/E ratio and 29.66% ROE. The company has beaten earnings estimates for three consecutive quarters, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent developments include the UPS Secure Commerce platform launch and TikTok Shop partnership, while analysts maintain a $118.67 consensus price target despite near-term margin pressures.
UPS presents a value opportunity with attractive valuation metrics and consistent earnings beats, though declining revenue and competitive pressures from Amazon pose challenges. The 7% dividend yield provides income support, but investors should monitor domestic package volume trends and margin sustainability given recent analyst downgrades and bearish technical indicators.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
